Home Search Search All Website Search for website content Search Popular search terms: Biotech Cell and Gene Therapies Consulting Early Clinical Medical Device Oncology Rare & Orphan Diseases Real World Evidence Site & Patient Recruitment Strategic Solutions Regulatory Intelligence Categories Social media ICON Plc We’re looking forward to participating in and hosting C-Path's annual eCOA Consortium EU meeting on October 8–9 at ICON’s Dublin office. This meeting brings together leading eCOA experts to address key industry challen... 21h 2 View post View webpage ICON Plc Cell and gene therapies offer a promising approach for the treating of autoimmune diseases, but their development presents unique challenges. Meet ICON experts at #ACR25, booth \#1501 to learn how our tailored strategi... 23h View post View webpage ICON Plc Visit the ICON team at #ACR25, booth 1501 to discover how our strategic solutions and innovative methods help reduce patient burden, meet enrolment targets, and accelerate access to new treatment options for autoimmune d... 23h 2 View post View webpage ICON Plc TOMORROW! Join ICON experts for a live webinar covering: • Evidence-based selection of measures in obesity trials • Best practices in ensuring data quality • Streamlined operational integration for more effective clinica... 6 Oct 1 View post View webpage ICON Plc Our Taipei team has been embracing wellness, creativity, and safety through a series of engaging initiatives. From celebrating the Mid-Autumn Festival with a colorful Pomelo Painting activity, to promoting heart health ... 6 Oct View post View webpage ICON Plc Drop by booth \#69 at #OCTNewEngland2025, 15– 16 October. Meet the ICON experts to explore new solutions to common issues within clinical trials. Learn how we can simplify processes to help you meet critical milestones, ... 3 Oct View post View webpage ICON Plc Drop by booth #69 at #OCTNewEngland2025, 15– 16 October. Meet the ICON experts to explore new solutions to common issues within clinical trials. Learn how we can simplify processes to help you meet critical milestones, o... 3 Oct 1 View post View webpage ICON Plc Despite increased female participation, most Clinical Outcome Assessments (COAs) are still designed around male biology. A recent analysis found that less than 10% of COAs were developed with female-specific populations.... 3 Oct View post View webpage ICON Plc We are proud to share that our colleagues in Sofia took part in the Race for the Cure® on 28 September. Race for the Cure is Europe’s largest sporting event for women’s health, bringing together communities to support b... 3 Oct View post ICON Plc ICH GCP E6(R3) is here. Are you ready? The new guideline introduces sweeping changes to clinical trial operations. In the latest issue of PharmaTimes, ICON’s own Joanne Perry explores why a comprehensive impact assessm... 3 Oct View post View webpage ICON Plc Big news in clinical research! The updated ICH GCP E6(R3) guideline is here and it’s changing how trials are designed and run. Our article in PharmaTimes explains why a detailed impact assessment is the first step to sta... 3 Oct 2 View post View webpage ICON Plc Join leading experts in #neuroscience and clinical development as they discuss how #biomarkers are transforming trials in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. This session will cover: - Inte... 2 Oct View post View webpage
